Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Torsemide or Torasemide is a loop or high ceiling diuretic with actions similar to those of furosemide. used to treat hypertension and edema associated with heart failure, kidney failure, or liver disease. It causes intense diuresis. Oral administration once daily.
Since the last update we have not found published data on its excretion in breastmilk.
Its pharmacokinetic data (very high percentage of protein binding and wide volume of distribution) make it highly unlikely that significant quantities will pass into breast milk.
Excessive diuresis can reduce milk production. In the past, diuretics and fluid restriction have been used to suppress lactation after calving. (Kall 1977)
Administration of torasemide in the first week after delivery did not decrease the frequency of initial lactation. (Viteri 2018)
Prolonged use of diuretics can inhibit lactation. It is advisable to use the lowest possible dose, especially the first month.